| 0 |
ANTI FACTOR VIII ANTIBODY POSITIVE |
37 |
| 1 |
DRUG INEFFECTIVE |
26 |
| 2 |
HAEMORRHAGE |
20 |
| 3 |
OFF LABEL USE |
14 |
| 4 |
DEATH |
8 |
| 5 |
FACTOR VIII INHIBITION |
8 |
| 6 |
PULMONARY EMBOLISM |
6 |
| 7 |
DEEP VEIN THROMBOSIS |
5 |
| 8 |
DRUG EFFECT DECREASED |
5 |
| 9 |
INHIBITING ANTIBODIES |
5 |
| 10 |
CONDITION AGGRAVATED |
4 |
| 11 |
HAEMATOMA |
4 |
| 12 |
MUSCLE HAEMORRHAGE |
4 |
| 13 |
PNEUMONIA |
4 |
| 14 |
THERAPEUTIC RESPONSE DECREASED |
4 |
| 15 |
ANTI FACTOR VIII ANTIBODY INCREASED |
3 |
| 16 |
COGNITIVE DISORDER |
3 |
| 17 |
COVID-19 |
3 |
| 18 |
EPILEPSY |
3 |
| 19 |
MENINGITIS ASEPTIC |
3 |
| 20 |
NO ADVERSE EVENT |
3 |
| 21 |
SEPSIS |
3 |
| 22 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
| 23 |
ABDOMINAL PAIN |
2 |
| 24 |
ATELECTASIS |
2 |
| 25 |
ATRIAL FIBRILLATION |
2 |
| 26 |
BILIARY DILATATION |
2 |
| 27 |
BRONCHIAL WALL THICKENING |
2 |
| 28 |
CEREBROVASCULAR ACCIDENT |
2 |
| 29 |
COAGULATION FACTOR VIII LEVEL ABNORMAL |
2 |
| 30 |
COAGULATION FACTOR VIII LEVEL DECREASED |
2 |
| 31 |
COVID-19 PNEUMONIA |
2 |
| 32 |
DECREASED APPETITE |
2 |
| 33 |
DELIRIUM |
2 |
| 34 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
| 35 |
EMBOLISM |
2 |
| 36 |
FALL |
2 |
| 37 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
| 38 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
| 39 |
GINGIVAL BLEEDING |
2 |
| 40 |
HIATUS HERNIA |
2 |
| 41 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
| 42 |
INTRA-ABDOMINAL HAEMORRHAGE |
2 |
| 43 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
| 44 |
NAUSEA |
2 |
| 45 |
NECROSIS |
2 |
| 46 |
NEUTROPENIA |
2 |
| 47 |
OXYGEN SATURATION DECREASED |
2 |
| 48 |
PLEURAL EFFUSION |
2 |
| 49 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
| 50 |
RENAL FAILURE |
2 |
| 51 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
2 |
| 52 |
THERAPY NON-RESPONDER |
2 |
| 53 |
THROMBOTIC MICROANGIOPATHY |
2 |
| 54 |
ACUTE RESPIRATORY FAILURE |
1 |
| 55 |
ANGIOPATHY |
1 |
| 56 |
ANTI FACTOR VIII ANTIBODY TEST |
1 |
| 57 |
ANTIBODY TEST POSITIVE |
1 |
| 58 |
BARRETT^S OESOPHAGUS |
1 |
| 59 |
BLOOD LOSS ANAEMIA |
1 |
| 60 |
BRONCHIAL HAEMORRHAGE |
1 |
| 61 |
CARDIOGENIC SHOCK |
1 |
| 62 |
CARDIOPULMONARY FAILURE |
1 |
| 63 |
CELLULITIS |
1 |
| 64 |
CHEMOTHERAPY |
1 |
| 65 |
CHEST WALL HAEMATOMA |
1 |
| 66 |
COAGULATION FACTOR VIII LEVEL INCREASED |
1 |
| 67 |
COLITIS ISCHAEMIC |
1 |
| 68 |
CONFUSIONAL STATE |
1 |
| 69 |
CONTUSION |
1 |
| 70 |
CORONARY ARTERY DISEASE |
1 |
| 71 |
DEHYDRATION |
1 |
| 72 |
DISCOMFORT |
1 |
| 73 |
DRUG CLEARANCE INCREASED |
1 |
| 74 |
DRUG EFFECT INCOMPLETE |
1 |
| 75 |
DYSGEUSIA |
1 |
| 76 |
DYSPNOEA |
1 |
| 77 |
EATING DISORDER |
1 |
| 78 |
EYELID PTOSIS |
1 |
| 79 |
FACTOR VIII ACTIVITY DECREASED |
1 |
| 80 |
FIBRIN D DIMER INCREASED |
1 |
| 81 |
HAEMARTHROSIS |
1 |
| 82 |
HAEMATOMA MUSCLE |
1 |
| 83 |
HAEMATURIA |
1 |
| 84 |
HAEMOPHILIA |
1 |
| 85 |
HAEMOTHORAX |
1 |
| 86 |
HOSPITALISATION |
1 |
| 87 |
HYPERCOAGULATION |
1 |
| 88 |
HYPOAESTHESIA |
1 |
| 89 |
IMPERFORATE OESOPHAGUS |
1 |
| 90 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 91 |
INFECTION |
1 |
| 92 |
INHIBITING ANTIBODIES POSITIVE |
1 |
| 93 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
1 |
| 94 |
INTESTINAL ISCHAEMIA |
1 |
| 95 |
KIDNEY INFECTION |
1 |
| 96 |
LEUKOPENIA |
1 |
| 97 |
LIP HAEMATOMA |
1 |
| 98 |
MASS |
1 |
| 99 |
MIXED DEMENTIA |
1 |
| 100 |
MYOCARDIAL INFARCTION |
1 |
| 101 |
NONINFECTIVE GINGIVITIS |
1 |
| 102 |
NONSPECIFIC REACTION |
1 |
| 103 |
OESOPHAGEAL HAEMORRHAGE |
1 |
| 104 |
ORAL CONTUSION |
1 |
| 105 |
ORAL DISCOMFORT |
1 |
| 106 |
OSTEOMYELITIS |
1 |
| 107 |
PETIT MAL EPILEPSY |
1 |
| 108 |
PHARYNGEAL HAEMORRHAGE |
1 |
| 109 |
PLEURISY |
1 |
| 110 |
PNEUMONIA KLEBSIELLA |
1 |
| 111 |
PNEUMONIA PSEUDOMONAL |
1 |
| 112 |
POOR VENOUS ACCESS |
1 |
| 113 |
POST PROCEDURAL CONTUSION |
1 |
| 114 |
POSTOPERATIVE ILEUS |
1 |
| 115 |
PRIAPISM |
1 |
| 116 |
PRODUCT DISTRIBUTION ISSUE |
1 |
| 117 |
PRODUCT USE ISSUE |
1 |
| 118 |
PROTEUS TEST POSITIVE |
1 |
| 119 |
PSEUDOMONAL SEPSIS |
1 |
| 120 |
PULMONARY SEPSIS |
1 |
| 121 |
RENAL IMPAIRMENT |
1 |
| 122 |
RESPIRATORY DISORDER |
1 |
| 123 |
RESPIRATORY TRACT INFECTION |
1 |
| 124 |
RESPIRATORY TRACT INFLAMMATION |
1 |
| 125 |
RETROPERITONEAL HAEMATOMA |
1 |
| 126 |
SEIZURE |
1 |
| 127 |
SKIN HAEMORRHAGE |
1 |
| 128 |
SPEECH DISORDER |
1 |
| 129 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
| 130 |
STAPHYLOCOCCAL SEPSIS |
1 |
| 131 |
SUBARACHNOID HAEMORRHAGE |
1 |
| 132 |
SUBDURAL HAEMATOMA |
1 |
| 133 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
| 134 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
| 135 |
THERAPEUTIC RESPONSE INCREASED |
1 |
| 136 |
THERAPY RESPONDER |
1 |
| 137 |
THROMBOCYTOPENIA |
1 |
| 138 |
TREATMENT FAILURE |
1 |
| 139 |
TREMOR |
1 |
| 140 |
UNDERDOSE |
1 |
| 141 |
UNEVALUABLE EVENT |
1 |
| 142 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
| 143 |
URETHRAL ABSCESS |
1 |
| 144 |
URINARY TRACT INFECTION |
1 |
| 145 |
UROSEPSIS |
1 |
| 146 |
VESSEL PUNCTURE SITE HAEMATOMA |
1 |
| 147 |
WOUND COMPLICATION |
1 |